$11.06
-0.27-2.38%
At close: -
$11.50
0.443.98%
After Hours: 9:27 AM EDT
Comments
Loading...
Neumora Therapeutics (NASDAQ:NMRA) Stock, Earnings Estimates, EPS, And Revenue
Neumora Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Neumora Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Neumora Therapeutics (NMRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $-0.45 | $-0.39 | -15.4 % |
| Jun 2024 | 2024-08-06 | $-0.37 | $-0.37 | 0.00 % |
| Mar 2024 | 2024-05-07 | $-0.34 | $-0.34 | 0.00 % |
| Dec 2023 | 2024-03-07 | $-0.71 | $-0.55 | -29.1 % |
Neumora Therapeutics (NMRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?
Neumora Therapeutics (NMRA) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Neumora Therapeutics (NASDAQ:NMRA)?
The Actual EPS was $-0.45, which missed the estimate of $-0.39.
What were Neumora Therapeutics’s (NASDAQ:NMRA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.